Oncology Trials - March 2025

We've compiled a list of just a few of the pharmaceutical trials in oncology that are currently recruiting participants.

Check out www.ClinicalTrials.gov and enter the ID below each study to learn more.

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

ClinicalTrials.gov ID NCT06764771

Sponsor Bristol-Myers Squibb

Phase 1/​2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

ClinicalTrials.gov ID NCT03785249

Sponsor Mirati Therapeutics Inc.

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

ClinicalTrials.gov ID NCT06488716

Sponsor Genentech, Inc.

A Clinical Trial to Assess COM503 in Participants with Advanced Solid Malignancies

ClinicalTrials.gov ID NCT06759649

Sponsor Compugen Ltd

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

ClinicalTrials.gov ID NCT06581432

Sponsor Boehringer Ingelheim

Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

ClinicalTrials.gov ID NCT04236414

Sponsor AstraZeneca

A Phase 1 Study of NM6603 in Advanced Solid Tumors

ClinicalTrials.gov ID NCT06046066

Sponsor NucMito Pharmaceuticals Co. Ltd.